3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
3
NETWORK
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
135
Neoplasms
37
Pancreatic Neoplasms
34
Stomach Neoplasms
27
Colonic Neoplasms
23
Neoplasm Metastasis
20
Rectal Neoplasms
17
Carcinoma, Non-Small-Cell Lung
15
Esophageal Neoplasms
10
Cholangiocarcinoma
10
Adenocarcinoma
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Biliary Tract Neoplasms
8
Adenocarcinoma Of Esophagus
8
Ovarian Neoplasms
7
Triple Negative Breast Neoplasms
6
Gallbladder Neoplasms
6
Esophageal Squamous Cell Carcinoma
6
Gastrointestinal Neoplasms
5
Digestive System Neoplasms
5
Breast Neoplasms
5
Advanced Solid Tumors
5
Squamous Cell Carcinoma of Head and Neck
4
Solid Tumors
4
Melanoma
4
Intestinal Neoplasms
4
Carcinoma, Pancreatic Ductal
4
Carcinoma, Hepatocellular
4
Advanced Solid Tumor
4
Small Cell Lung Carcinoma
3
Interventions
pegfilgrastim
22
Filgrastim
11
Cyclophosphamide
7
Docetaxel
6
eflapegrastim
4
pegylated granulocyte colony-stimulating factor
3
Vancomycin
2
Itraconazole
2
Granulocyte Colony-Stimulating Factor
2
Fluorouracil
2
Doxorubicin
2
posaconazole
1
ceftobiprole medocaril
1
angiotensin I (1-7)
1
Teicoplanin
1
Sodium Chloride
1
Oxaliplatin
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Methotrexate
1
Maxy G34
1
Mannose-Binding Lectin
1
MYL-1401H
1
Leucovorin
1
Fluconazole
1
EC regimen
1
Diet, High-Fat
1
Cefepime
1
Bevacizumab
1
Amphotericin B
1
1-palmitoyl-2-linoleoyl-3-acetyl-rac glycerol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neutropenia
×
Leucovorin
×
Clear all
NCT02135887
2020-12-22
MB-6
Microbio Co Ltd
Unknown
184 enrolled